XTX Topco’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-642
| Closed | -$16K | – | 2638 |
|
|
2024
Q4 | $16K | Buy |
642
+393
| +158% | +$9.79K | ﹤0.01% | 2071 |
|
|
2024
Q3 | $4.21K | Buy |
+249
| New | +$4.21K | ﹤0.01% | 1979 |
|
|
2024
Q1 | – | Sell |
-111
| Closed | -$26.2K | – | 2017 |
|
|
2023
Q4 | $26.2K | Sell |
111
-216
| -66% | -$50.9K | 0.01% | 1329 |
|
|
2023
Q3 | $49.1K | Buy |
327
+27
| +9% | +$4.05K | 0.01% | 1282 |
|
|
2023
Q2 | $52.2K | Buy |
+300
| New | +$52.2K | 0.01% | 1234 |
|
|
2023
Q1 | – | Sell |
-636
| Closed | -$193K | – | 1422 |
|
|
2022
Q4 | $193K | Buy |
+636
| New | +$193K | 0.04% | 860 |
|
|
2021
Q3 | – | Sell |
-590
| Closed | -$137K | – | 812 |
|
|
2021
Q2 | $137K | Buy |
+590
| New | +$137K | 0.05% | 620 |
|